Home / Health / The oral corona vaccine was developed by the owners of the LA Lakers.

The oral corona vaccine was developed by the owners of the LA Lakers.



One of the owners of the Los Angeles Lakers is developing a non-invasive coronavirus vaccine.

Dr Patrick Soon-Shiong and his team of researchers are testing whether the oral drug can work with or better than the Food and Drug Administration-approved vaccine, CBS Los Angeles reports.

All three vaccines licensed for emergencies in the United States – from Pfizer-BioNTech, Moderna and Johnson & Johnson – work by creating protein-blocking antibodies that the corona virus uses to enter and infect human cells.

But the team’s new vaccine targets the Earth-like shape in the middle of the virus, often not mutated.

The team also said the vaccine is faster, cheaper and easier to administer because it doesn̵

7;t need to be stored in the refrigerator or freezing temperatures.

Researchers at the Chan Soon-Shiong Research Institute are developing a new oral (above) COVID-19 vaccine that targets the Earth-like shape in the middle of the virus.

Researchers at the Chan Soon-Shiong Research Institute are developing a new oral (above) COVID-19 vaccine that targets the Earth-like shape in the middle of the virus.

One developer, Dr Patrick Soon-Shiong (pictured), part owner of the Los Angeles Lakers, said the new vaccine creates T cells, which capture and kill the virus.

One developer, Dr Patrick Soon-Shiong (pictured), part owner of the Los Angeles Lakers, said the new vaccine creates T cells, which capture and kill the virus.

‘Having a vaccine at room temperature, which could be a pill, is life-changing,’ said one researcher Dr. Tara Serie of the Chan Soon-Shiong Institute of Medical Research in El Segundo, Calif., Told CBS Los Angeles.

For the trial, which is currently in phase 1, the team divided the subjects into four groups to see how well the drugs worked.

One group received only the drugs, the second received only injections, the third received the drug and injections, and the fourth received both.

The new vaccine also targets a part of the coronavirus that is less likely to mutate.

Most of the known strains, including from the United Kingdom, South Africa and Brazil, have had mutations affecting the viral blocking protein.

This protein is what coronavirus uses to ‘hijack’ human cells, make multiple copies of itself, and spread throughout the body.

But a new oral vaccine attacks the center of the virus, called a lipid bilayer, a sachet that contains a protein block.

‘And the value of doing so is that we make killer T cells,’ Soon-Shiong told CBS Los Angeles.

T cells are a type of white blood cell that binds and kills viruses.

The team believes that by creating both the antibody and the T receptor cells, they will be protected that lasts for a long time.

On average, about three million adults are vaccinated daily, with a single-day total reaching four million over the weekend.

On average, about three million adults are vaccinated daily, with a single-day total reaching four million over the weekend.

Currently, 108.3 million Americans - 32.6% of the population - have received at least one dose and 63 million - 19% - are fully vaccinated.

Currently, 108.3 million Americans – 32.6% of the population – have received at least one dose and 63 million – 19% – are fully vaccinated.

Soon-Chong said researchers are testing a combination of vaccinations and oral vaccines because he believes we may need both to defeat the virus.

‘The jab, we hope to develop T cells throughout your body,’ he told the station.

‘And by giving it orally, we protect the mucous, gut, and hopefully the nose, mouth, because that’s the way the virus comes in, it doesn’t get into your blood.’

The trial was open to adults between the ages of 18 and 55 who had never tested positive for COVID-19 and who were not immunocompromised. Those who wish to register can visit here.

According to the Centers for Disease Control and Prevention, 108.3 million Americans – 32.6 percent of the population received at least one dose and 63 million – 19 percent were fully vaccinated.

On average, about three million adults are vaccinated daily, with a single-day total reaching four million over the weekend.


Source link